E.M. Kolassa, MBA, PhD


Drug Development through Modeling and Simulation - the Business Case

July 25, 2016

The drug development process has been seen as inefficient and disappointing by those in the R&D space. Model and Simulation provides a potential relief to these issues by delivering significant business, scientific and clinical value to drug developers.